Ivana Micallef, MD

  • 7343 Citations
  • 48 Scopus h-Index
19982019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1998 2019

  • 7343 Citations
  • 48 Scopus h-Index
  • 138 Article
  • 1 Comment/debate
  • 1 Letter
Filter
Article
2019

Autograft immune content and survival in non-Hodgkin's lymphoma: A post hoc analysis

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Villasboas Bisneto, J. J. C. . & Markovic, S. N., Jun 1 2019, In : Leukemia Research. 81, p. 1-9 9 p.

Research output: Contribution to journalArticle

Autografts
Peripheral Blood Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Non-Hodgkin's Lymphoma
Survival
Follicular Lymphoma
Spleen
Bone and Bones
Survival
Disease-Free Survival
1 Citation (Scopus)

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Lymphoma
Recurrence
Germinal Center
B-Lymphocytes

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo, M., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Micallef, I. N., Johnston, P. B., Inwards, D. J., Botto, B., Ristow, K. M., Young, J. R., Vitolo, U. & Ansell, S. M., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Hodgkin Disease
Biopsy
Salvage Therapy
Therapeutics
Positron Emission Tomography Computed Tomography
2018
21 Citations (Scopus)

Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials

Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 others, Slager, S. L., Weiner, G. J., Ansell, S. M., Cerhan, J. R., Salles, G. A., Witzig, T. E., Tilly, H. & Nowakowski, G. S., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Clinical Trials
Lymphoma
Therapeutics
Selection Bias
3 Citations (Scopus)

History of autoimmune conditions and lymphoma prognosis

Kleinstern, G., Maurer, M. J., Liebow, M., Habermann, T. M., Koff, J. L., Allmer, C., Witzig, T. E., Nowakowski, G. S., Micallef, I., Johnston, P. B., Inwards, D. J., Thompson, C. A., Feldman, A. L., Link, B. K., Flowers, C., Slager, S. L. & Cerhan, J. R., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 73.

Research output: Contribution to journalArticle

Lymphoma
Disease-Free Survival
Hodgkin Disease
B-Lymphocytes
Survival
3 Citations (Scopus)
Autografts
Stem Cell Transplantation
HLA-DR Antigens
Natural Killer Cells
Lymphoma
5 Citations (Scopus)

Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report

Micallef, I., Stiff, P. J., Nademanee, A. P., Maziarz, R. T., Horwitz, M. E., Stadtmauer, E. A., Kaufman, J. L., McCarty, J. M., Vargo, R., Cheverton, P. D., Struijs, M., Bolwell, B. & DiPersio, J. F., Jun 1 2018, In : Biology of Blood and Marrow Transplantation. 24, 6, p. 1187-1195 9 p.

Research output: Contribution to journalArticle

Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Non-Hodgkin's Lymphoma
Confidence Intervals
Placebos
3 Citations (Scopus)
Methotrexate
Lymphoma
Survival
Central Nervous System
Recurrence
2017

A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma

Dispenzieri, A., D'Souza, A., Gertz, M., Laumann, K., Wiseman, G., Lacy, M., LaPlant, B., Buadi, F., Hayman, S. R., Kumar, S. K., Dingli, D. M., Hogan, W., Ansell, S. M., Gastineau, D. A., Inwards, D. J., Micallef, I., Porrata, L. F., Johnston, P. B., Litzow, M. R. & Witzig, T. E., Oct 1 2017, In : Bone Marrow Transplantation. 52, 10, p. 1372-1377 6 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Multiple Myeloma
Stem Cells
Transplants
Melphalan
10 Citations (Scopus)

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy

Farooq, U., Maurer, M. J., Thompson, C. A., Thanarajasingam, G., Inwards, D. J., Micallef, I., Macon, W., Syrbu, S., Lin, T., Lin, Y., Ansell, S. M., Nowakowski, G. S., Habermann, T. M., Cerhan, J. R. & Link, B. K., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 50-60 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Anthracyclines
Recurrence
Survival
Transplants
14 Citations (Scopus)
cohort analysis
disease incidence
Molecular Epidemiology
epidemiology
research program
43 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
9 Citations (Scopus)

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma

Bennani, N., LaPlant, B. R., Ansell, S. M., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Macon, W. R., Reeder, C. B., Mikhael, J. R., Northfelt, D. W., Ghobrial, I. M. & Witzig, T. E., May 1 2017, In : American Journal of Hematology. 92, 5, p. 448-453 6 p.

Research output: Contribution to journalArticle

Lymphoma
Therapeutics
Safety
Febrile Neutropenia
Everolimus
7 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Everolimus
94 Citations (Scopus)

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Ding, W. D., LaPlant, B. R., Call, T. G., Parikh, S. A., Leis, J. F., He, R., Shanafelt, T. D., Sinha, S., Le-Rademacher, J., Feldman, A. L., Habermann, T. M., Witzig, T. E., Wiseman, G. A., Lin, Y., Asmus, E., Nowakowski, G. S., Conte, M. J., Bowen, D. A., Aitken, C. N., Van Dyke, D. L. & 15 others, Greipp, P. T., Liu, X., Wu, X., Zhang, H., Secreto, C. R., Tian, S., Braggio, E. D., Wellik, L. E., Micallef, I., Viswanatha, D. S., Yan, H. D., Chanan Khan, A. A., Kay, N. E., Dong, H. M. & Ansell, S. M., Jun 29 2017, In : Blood. 129, 26, p. 3419-3427 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Tumors
Blocking Antibodies
Ligands
pembrolizumab
6 Citations (Scopus)

Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma

Epperla, N., Pham, A. Q., Burnette, B. L., Wiseman, G. A., Habermann, T. M., Macon, W. R., Ansell, S. M., Inwards, D. J., Micallef, I., Johnston, P. B., Markovic, S. N., Porrata, L. F., Colgan, J. P., Ristow, K. M., Nowakowski, G. S. & Witzig, T. E., 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Radioimmunotherapy
Follicular Lymphoma
Acute Myeloid Leukemia
Myelodysplastic Syndromes
Therapeutics
5 Citations (Scopus)

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma

Tracy, S. I., Maurer, M. J., Witzig, T. E., Drake, M. M., Ansell, S. M., Nowakowski, G. S., Thompson, C. A., Inwards, D. J., Johnston, P. B., Micallef, I., Allmer, C., MacOn, W. R., Weiner, G. J., Slager, S. L., Habermann, T. M., Link, B. K. & Cerhan, J. R., Aug 25 2017, In : Blood Cancer Journal. 7, 8, e595.

Research output: Contribution to journalArticle

Follicular Lymphoma
Vitamin D
Confidence Intervals
Lymphoma
Odds Ratio
2016
24 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Safety
Disease-Free Survival
National Cancer Institute (U.S.)
Everolimus
19 Citations (Scopus)

Large b-cell transformation in nodular lymphocyte-predominant hodgkin lymphoma: 40-year experience from a single institution

Kenderian, S., Habermann, T. M., Macon, W. R., Ristow, K. M., Ansell, S. M., Colgan, J. P., Johnston, P. B., Inwards, D. J., Markovic, S. N., Micallef, I., Thompson, C. A., Porrata, L. F., Martenson, J. A., Witzig, T. E. & Nowakowski, G. S., Apr 21 2016, In : Blood. 127, 16, p. 1960-1966 7 p.

Research output: Contribution to journalArticle

Lymphocytes
Hodgkin Disease
Lymphoma, Large B-Cell, Diffuse
Chemotherapy
Cells
13 Citations (Scopus)

Personalized risk prediction for event-free survival at 24 months in patients with diffuse large B-cell lymphoma

Maurer, M. J., Jais, J. P., Ghesquières, H., Witzig, T. E., Hong, F., Haioun, C., Thompson, C. A., Thieblemont, C., Micallef, I., Porrata, L. F., Ribrag, V., Nowakowski, G. S., Casasnovas, O., Bologna, S., Morschhauser, F., Morrison, V. A., Peterson, B. A., Macon, W. R., Copie-Bergman, C., Feldman, A. L. & 13 others, Syrbu, S. I., Kurtin, P. J., Gascoyne, R. D., Li, H., Allmer, C., Kahl, B. S., Ansell, S. M., Slager, S. L., Link, B. K., Salles, G., Habermann, T. M., Tilly, H. & Cerhan, J. R., Feb 1 2016, In : American Journal of Hematology. 91, 2, p. 179-184 6 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Survival
Anthracyclines
Datasets
2015
12 Citations (Scopus)

A phase II trial of RCHOP followed by radioimmunotherapy for early stage (stages I/II) diffuse large B-cell non-Hodgkin lymphoma: ECOG3402

Witzig, T. E., Hong, F., Micallef, I., Gascoyne, R. D., Dogan, A., Wagner, H., Kahl, B. S., Advani, R. H. & Horning, S. J., Sep 1 2015, In : British Journal of Haematology. 170, 5, p. 679-686 8 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Vincristine
B-Cell Lymphoma
Prednisone
Non-Hodgkin's Lymphoma
7 Citations (Scopus)

Immunologic Autograft Engineering and Survival in Non-Hodgkin Lymphoma

Porrata, L. F., Burgstaler, E. A., Winters, J. L., Jacob, E. K., Gastineau, D. A., Suman, V. J., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Nevala, W. & Markovic, S. N., Sep 23 2015, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Autografts
Lymphocyte Count
Non-Hodgkin's Lymphoma
Survival
Peripheral Blood Stem Cell Transplantation
3 Citations (Scopus)
Peripheral Blood Stem Cell Transplantation
T-Cell Lymphoma
Hematopoietic Stem Cell Transplantation
Autografts
Monocytes
7 Citations (Scopus)

Infused autograft lymphocyte to monocyte ratio predicts survival in classical Hodgkin lymphoma

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Hogan, W. & Markovic, S. N., Feb 2 2015, In : Journal of Blood Medicine. 6, p. 45-53 9 p.

Research output: Contribution to journalArticle

Autografts
Hodgkin Disease
Monocytes
Lymphocytes
Survival
194 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Phenotype
Germinal Center
Disease-Free Survival
44 Citations (Scopus)

The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma

Witzig, T. E., Reeder, C., Han, J. J., LaPlant, B., Stenson, M., Tun, H. W., Macon, W., Ansell, S. M., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Colgan, J. P., Markovic, S. N., Nowakowski, G. S. & Gupta, M., Jul 16 2015, In : Blood. 126, 3, p. 328-335 8 p.

Research output: Contribution to journalArticle

T-cells
T-Cell Lymphoma
Tumors
Sirolimus
Confidence Intervals
2014
9 Citations (Scopus)

Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non-Hodgkin lymphoma

Witzig, T. E., Maurer, M. J., Habermann, T. M., Link, B. K., Micallef, I., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Markovic, S. N., Johnston, P. B., Lin, Y., Thompson, C. A., Gupta, M., Katzmann, J. A. & Cerhan, J. R., Dec 1 2014, In : American Journal of Hematology. 89, 12, p. 1116-1120 5 p.

Research output: Contribution to journalArticle

Immunoglobulin Light Chains
T-Cell Lymphoma
Non-Hodgkin's Lymphoma
Light
Serum
114 Citations (Scopus)

Event-free survival at 24 months is a robust end point for disease-related outcome in diffuse large B-cell lymphoma treated with immunochemotherapy

Maurer, M. J., Ghesquières, H., Jais, J. P., Witzig, T. E., Haioun, C., Thompson, C. A., Delarue, R., Micallef, I., Peyrade, F., Macon, W. R., Molina, T. J., Ketterer, N., Syrbu, S. I., Fitoussi, O., Kurtin, P. J., Allmer, C., Nicolas-Virelizier, E., Slager, S. L., Habermann, T. M., Link, B. K. & 3 others, Salles, G., Tilly, H. & Cerhan, J. R., Apr 1 2014, In : Journal of Clinical Oncology. 32, 10, p. 1066-1073 8 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Disease-Free Survival
Molecular Epidemiology
Population
Survival
15 Citations (Scopus)

Infused autograft lymphocyte to monocyte ratio and survival in diffuse large B cell lymphoma

Porrata, L. F., Inwards, D. J., Ansell, S. M., Micallef, I., Johnston, P. B., Hogan, W. & Markovic, S. N., Nov 1 2014, In : Biology of Blood and Marrow Transplantation. 20, 11, p. 1804-1812 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Autografts
Monocytes
Lymphocytes
Survival
35 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Vincristine
Prednisone
Doxorubicin
Cyclophosphamide
85 Citations (Scopus)

Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma

Thompson, C. A., Ghesquieres, H., Maurer, M. J., Cerhan, J. R., Biron, P., Ansell, S. M., Chassagne-Clément, C., Inwards, D. J., Gargi, T., Johnston, P. B., Nicolas-Virelizier, E., Macon, W. R., Peix, M., Micallef, I., Sebban, C., Nowakowski, G. S., Porrata, L. F., Weiner, G. J., Witzig, T. E., Habermann, T. M. & 1 others, Link, B. K., Nov 1 2014, In : Journal of Clinical Oncology. 32, 31, p. 3506-3512 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Recurrence
Molecular Epidemiology
Therapeutics
France
2013

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

Larsen, J. T., Hogan, W., Micallef, I., Dispenzieri, A., Gertz, M., Inwards, D. J., Tun, H. W., Roy, V., Geyer, S. M., Allred, J. B., Wu, W., Ansell, S. M., Elliott, M. A., Tefferi, A., Porrata, L. F., Gastineau, D. A., Lacy, M. & Litzow, M. R., Aug 2013, In : Leukemia and Lymphoma. 54, 8, p. 1713-1718 6 p.

Research output: Contribution to journalArticle

Cladribine
Thiotepa
Antilymphocyte Serum
Hematologic Neoplasms
Rabbits
17 Citations (Scopus)

A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma

Witzig, T. E., Wiseman, G. A., Maurer, M. J., Habermann, T. M., Micallef, I., Nowakowski, G. S., Ansell, S. M., Colgan, J. P., Inwards, D. J., Porrata, L. F., Link, B. K., Zent, C. S., Johnston, P. B., Shanafelt, T. D., Allmer, C., Asmann, Y., Gupta, M., Ballas, Z. K., Smith, B. J. & Weiner, G. J., Jul 2013, In : American Journal of Hematology. 88, 7, p. 589-593 5 p.

Research output: Contribution to journalArticle

Radioimmunotherapy
Oligodeoxyribonucleotides
B-Cell Lymphoma
Non-Hodgkin's Lymphoma
B-Lymphocytes
41 Citations (Scopus)

Bowel perforation in intestinal lymphoma: Incidence and clinical features

Vaidya, R., Habermann, T. M., Donohue, J. H., Ristow, K. M., Maurer, M. J., Macon, W. R., Colgan, J. P., Inwards, D. J., Ansell, S. M., Porrata, L. F., Micallef, I., Johnston, P. B., Markovic, S. N., Thompson, C. A., Nowakowski, G. S. & Witzig Dr., T. E., Sep 2013, In : Annals of Oncology. 24, 9, p. 2439-2443 5 p., mdt188.

Research output: Contribution to journalArticle

Intestinal Perforation
Lymphoma
Incidence
B-Cell Lymphoma
Drug Therapy
53 Citations (Scopus)

Cost-Effectiveness Analysis of a Risk-Adapted Algorithm of Plerixafor Use for Autologous Peripheral Blood Stem Cell Mobilization

Micallef, I., Sinha, S., Gastineau, D. A., Wolf, R., Inwards, D. J., Gertz, M., Hayman, S. R., Hogan, W., Johnston, P. B., Lacy, M., Ansell, S. M., Buadi, F., Dingli, D. M., Dispenzieri, A., Litzow, M. R., Porrata, L. F., Winters, J. L. & Kumar, S. K., Jan 2013, In : Biology of Blood and Marrow Transplantation. 19, 1, p. 87-93 7 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Cost-Benefit Analysis
Blood Component Removal
Granulocyte Colony-Stimulating Factor
Costs and Cost Analysis
13 Citations (Scopus)

Incidence of Supraventricular Arrhythmias during Autologous peripheral blood stem cell transplantation

Singla, A., Hogan, W., Ansell, S. M., Buadi, F. K., Dingli, D. M., Dispenzieri, A., Gastineau, D. A., Gertz, M., Hayman, S. R., Inwards, D. J., Johnston, P. B., Lacy, M., Litzow, M. R., Micallef, I., Porrata, L. F. & Kumar, S. K., Aug 2013, In : Biology of Blood and Marrow Transplantation. 19, 8, p. 1233-1237 5 p.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
Cardiac Arrhythmias
Cell Transplantation
Incidence
Atrial Flutter
49 Citations (Scopus)
Immunoglobulin Light Chains
Stem Cell Transplantation
Amyloidosis
Multiple Myeloma
Tertiary Care Centers
17 Citations (Scopus)
Tumor Microenvironment
Hodgkin Disease
Monocytes
Lymphocytes
Therapeutics
1 Citation (Scopus)

Phase i study of a modified regimen of 90yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed cd20+ non-hodgkin lymphoma

Vaklavas, C., Meredith, R. F., Shen, S., Knox, S. J., Micallef, I., Shah, J. J., Lobuglio, A. F. & Forero-Torres, A., Jun 17 2013, In : Cancer Biotherapy and Radiopharmaceuticals. 28, 5, p. 370-379 10 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Bone Marrow
B-Lymphocytes
Radioimmunotherapy
Maximum Tolerated Dose
24 Citations (Scopus)

Plerixafor and G-CSF for autologous stem cell mobilization in patients with NHL, Hodgkin's lymphoma and multiple myeloma: Results from the expanded access program

Shaughnessy, P., Uberti, J., Devine, S., Maziarz, R. T., Vose, J., Micallef, I., Jacobsen, E., McCarty, J., Stiff, P., Artz, A., Ball, E. D., Berryman, R., Dugan, M., Joyce, R., Hsu, F. J., Johns, D. & McSweeney, P., Jun 1 2013, In : Bone Marrow Transplantation. 48, 6, p. 777-781 5 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Multiple Myeloma
Hodgkin Disease
Granulocytes
Non-Hodgkin's Lymphoma
27 Citations (Scopus)

Plerixafor Plus Granulocyte Colony-Stimulating Factor Improves the Mobilization of Hematopoietic Stem Cells in Patients with Non-Hodgkin Lymphoma and Low Circulating Peripheral Blood CD34+ Cells

Maziarz, R. T., Nademanee, A. P., Micallef, I., Stiff, P. J., Calandra, G., Angell, J., DiPersio, J. F. & Bolwell, B. J., Apr 1 2013, In : Biology of Blood and Marrow Transplantation. 19, 4, p. 670-675 6 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Granulocyte Colony-Stimulating Factor
Non-Hodgkin's Lymphoma
Blood Cells
Placebos
18 Citations (Scopus)

Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34+ hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma

Micallef, I., Stiff, P. J., Stadtmauer, E. A., Bolwell, B. J., Nademanee, A. P., Maziarz, R. T., Partisano, A. M., Marulkar, S. & Dipersio, J. F., Dec 1 2013, In : American Journal of Hematology. 88, 12, p. 1017-1023 7 p.

Research output: Contribution to journalArticle

Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cells
Multiple Myeloma
Non-Hodgkin's Lymphoma
Placebos
2012
41 Citations (Scopus)
Lymphoma, Large B-Cell, Diffuse
Lymphocyte Count
Monocytes
Survival
Disease-Free Survival
39 Citations (Scopus)

Expression of Myc, but not pSTAT3, is an adverse prognostic factor for diffuse large B-cell lymphoma treated with epratuzumab/R-CHOP

Gupta, M., Maurer, M. J., Wellik, L. E., Law, M. E., Han, J. J., Ozsan, N., Micallef, I., Dogan, A. & Witzig, T. E., Nov 22 2012, In : Blood. 120, 22, p. 4400-4406 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Cells
Germinal Center
Tumors
27 Citations (Scopus)

Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma

Holtan, S. G., O'Connor, H. M., Fredericksen, Z. S., Liebow, M., Thompson, C. A., Macon, W. R., Micallef, I., Wang, A. H., Slager, S. L., Habermann, T. M., Call, T. G. & Cerhan, J. R., Sep 1 2012, In : International Journal of Cancer. 131, 5, p. 1158-1168 11 p.

Research output: Contribution to journalArticle

Non-Hodgkin's Lymphoma
Antioxidants
Odds Ratio
Food
Vegetables
9 Citations (Scopus)

Hematopoietic recovery kinetics predicts for poor CD34+ cell mobilization after cyclophosphamide chemotherapy in multiple myeloma

Ozsan, G. H., Micallef, I., Dispenzieri, A., Kumar, S. K., Lacy, M., Dingli, D. M., Hayman, S. R., Buadi, F. K., Wolf, R. C., Gastineau, D. A., Hogan, W. & Gertz, M., Jan 2012, In : American Journal of Hematology. 87, 1, p. 1-4 4 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Cyclophosphamide
Drug Therapy
Blood Component Removal
Blood Cells
9 Citations (Scopus)

Hematopoietic stem cells from poor and good mobilizers are qualitatively equivalent

Jiang, L., Malik, S., Litzow, M. R., Gastineau, D., Micallef, I., Roy, V., Solberg, L. & Zubair, A., Mar 2012, In : Transfusion. 52, 3, p. 542-548 7 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Neutrophils
Blood Platelets
Cell Count
CD34 Antigens
79 Citations (Scopus)

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): A single-center experience

D'Souza, A., Lacy, M., Gertz, M., Kumar, S. K., Buadi, F., Hayman, S., Dingli, D. M., Zeldenrust, S., Kyle, R., Ansell, S. M., Inwards, D., Johnston, P. B., Micallef, I., Porrata, L., Litzow, M. R., Gastineau, D., Hogan, W. & Dispenzieri, A., Jul 5 2012, In : Blood. 120, 1, p. 56-62 7 p.

Research output: Contribution to journalArticle

POEMS Syndrome
Stem Cell Transplantation
Stem cells
Hazards
Confidence Intervals
9 Citations (Scopus)
Hematopoietic Stem Cell Mobilization
Thalidomide
Granulocyte Colony-Stimulating Factor
Multiple Myeloma
Antineoplastic Agents